Brockman forecasts rapid AI advances in biology and disease treatment
OpenAI co-founder and president Greg Brockman said at WSJ Tech that AI could deliver significant advances in biology, healthcare and disease treatment within 12 to 18 months. He also raised the possibility that death could eventually become a choice, but the supplied reports present that idea as speculative and provide no evidence of a deployed capability.
The remarks represent a notable forecast from an OpenAI executive about the near-term impact of AI on healthcare and biology, while the broader longevity claims remain unverified.
IT之家 11 月 5 日消息,自人类拥有自我意识以来,死亡始终是困扰人类思想的一大难题,犹如一个至今仍无法找到有效解法的复杂谜题。不过,人工智能(AI)或许能在不久的将来帮助人类实现某些形式的永生,甚至让死亡成为一种可以自主选择的事情。OpenAI 总裁格雷格 · 布罗克曼(Greg Brockman)近日发表了这一观点,而他的看法与埃隆 · 马斯克(Elon Musk)此前表达的类似观点不谋而合。

OpenAI 联合创始人兼总裁格雷格 · 布罗克曼近日在《华尔街日报》科技峰会(WSJ Tech)上发表演讲,谈到了 AI 即将在生物学领域推动的一系列创新。他指出,未来死亡或许真的会成为一种选择。